The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Converting a 401k to a retirement plan can be a strategic move. Learn when it's the right time to make that transition.
20,599 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
NVIDIA delivered a blockbuster quarter with $68.13B in revenue, led by data center strength and a growing backlog for...
NVIDIA shares jumped roughly 2% on Monday after announcing energy-grid partnerships and BioNeMo collaborations, signa...
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
MISMO and ALTA unveiled two datasets in candidate recommendation status to digitize ALTA title and settlement data, s...
Chubb CEO Evan Greenberg releases a 25-page shareholder letter detailing strategic views on AI, China, and democracy’...
Bernstein boosts its ServiceNow price target to $236 after the company's Analyst Day, underscoring margin upside even...
Morgan Stanley and Charles Schwab are integrating direct crypto trading into ordinary brokerage accounts, aiming to c...
PI tumbled again as conference buzz fades and the project presses ahead with roadmap milestones. Analysts frame it as...
A standout quarterly report helped Rhythm Pharmaceuticals stock surge on Tuesday as investors embraced better-than-ex...
ZoomInfo's go-to-market approach is evolving as 2026 unfolds. This analysis breaks down the GTM moves behind the earn...
QuantumScape stock rallies on the Eagle Line milestone and early customer billings, signaling a shift from research t...